Associative Memory in Autism Spectrum Disorder

NCT ID: NCT02265094

Last Updated: 2018-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-12-22

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to investigate the neural substrates of associative memory in Autism Spectrum Disorder using both behavioural and EEG assessments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autistic Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

Electroencephalography and neuropsychological tests in children with autism

Group Type EXPERIMENTAL

Electroencephalography

Intervention Type OTHER

EEG recordings during memory tests

Neuropsychological assessment

Intervention Type BEHAVIORAL

patterns of eye gaze during cognitive tests

Control

Electroencephalography and neuropsychological tests in children without autism

Group Type EXPERIMENTAL

Electroencephalography

Intervention Type OTHER

EEG recordings during memory tests

Neuropsychological assessment

Intervention Type BEHAVIORAL

patterns of eye gaze during cognitive tests

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electroencephalography

EEG recordings during memory tests

Intervention Type OTHER

Neuropsychological assessment

patterns of eye gaze during cognitive tests

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Right handed children from 10 to 18 years old
* Informed consent signed by the legal representative and adolescent himself.

Exclusion Criteria

* People with ASD:

* Participants with ASD without mental retardation with a diagnosis in reference to the DSM V criteria
* Controls : Participants without ASD


* mental retardation,
* schizophrenia,
* ADHD,
* head injury with lost of consciousness
Minimum Eligible Age

10 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role collaborator

Amiens University Hospital

OTHER

Sponsor Role collaborator

University Hospital, Caen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Marc BALEYTE, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Caen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Caen University Hospital

Caen, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bérengère GUILLERY-GIRARD, PhD

Role: CONTACT

0231064347

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Baleyte Jean Marc

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014- A00481-46

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.